Effect of Exenatide on Metabolic and Inflammatory Markers in Diabetic Obese Patients

Authors : Eşref Araç, Mahsun Çağlin

Pages : 96-100

Doi:10.56016/dahudermj.1653914

View : 39 | Download : 32

Publication Date : 2025-07-29

Article Type : Research Paper

Abstract :Background: This study aimed to evaluate the effects of exenatide treatment on metabolic and inflammatory markers in patients with type 2 diabetes and obesity. Methods: This retrospective study included 119 patients diagnosed with type 2 diabetes and obesity who were treated at Dicle University Hospital between July 1, 2013, and December 31, 2019. Patients’ metabolic and inflammatory markers before and after 6 months of exenatide treatment were compared. Results: The mean age of the patients was 52.26±8.93 years; 17.6% were male, and 82.4% were female. After 6 months of exenatide treatment, significant decreases were observed in the LDH/albumin and CRP/albumin ratios (p<0.05) fasting glucose (160.5 ± 35.2 to 135.8 ± 28.9 mg/dL), HbA1c (8.5 ± 1.2% to 7.2 ± 1.1%), and BMI (34.5 ± 4.2 to 32.8 ± 3.9 kg/m²) (p<0.05). Comorbidities like hypertension and dyslipidemia also showed improvement. Conclusion: Exenatide treatment demonstrated favorable effects on both metabolic and inflammatory markers in diabetic obese patients. These findings suggest that exenatide may play a beneficial role in the management of chronic inflammation and metabolic control in this patient group.
Keywords : Tip 2 diyabet, obezite, eksenatid, metabolik belirteçler, inflamatuar belirteçler.

ORIGINAL ARTICLE URL